Alphatec Holdings, Inc. (ATEC) vs Intellia Therapeutics, Inc. (NTLA)
A side-by-side comparison of Alphatec Holdings, Inc. and Intellia Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ATEC
Alphatec Holdings, Inc.
$10.72HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
NTLA
Intellia Therapeutics, Inc.
$12.75HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ATEC vs NTLA
growth of $100 · dividends reinvested · last 10yATEC +46.2% (+3.9%/yr)NTLA -26.5% (-3.0%/yr)ATEC compounded faster over this window
ATEC NTLA
ATEC vs NTLA: by the numbers
- •NTLA is the larger company ($1.78B vs $1.65B market cap).
- •Both run net losses; ATEC's is the smaller (-13.50% vs -672.16% net margin).
- •ATEC grew revenue faster over the past five years (33.61% vs 7.31% CAGR).
Metrics side by side
Valuation
| Metric | ATEC | NTLA |
|---|---|---|
| Forward P/E | 32.82 | N/A |
| P/S ratio | 2.02 | 29.94 |
| P/B ratio | N/A | 2.45 |
| EV / EBITDA | 57.39 | N/A |
| FCF yield | 0.25% | N/A |
Profitability
| Metric | ATEC | NTLA |
|---|---|---|
| Gross margin | 66.15% | 76.47% |
| Operating margin | -5.55% | -651.67% |
| Net margin | -13.50% | -672.16% |
| ROE | N/A | -54.96% |
| ROIC | -7.32% | -54.45% |
Growth (annualized)
| Metric | ATEC | NTLA |
|---|---|---|
| Revenue CAGR (5Y) | 33.61% | 7.31% |
| Total return CAGR (5Y) | -2.26% | -37.13% |
Frequently asked
- Which has grown faster, ATEC or NTLA?
- Over the past five years, ATEC grew revenue faster — ATEC at a 33.61% CAGR versus NTLA at 7.31%.
- How have ATEC and NTLA total returns compared?
- Over the past 10 years, ATEC delivered 3.88% and NTLA delivered -3.03% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Alphatec ROEIntellia Therapeutics ROEAlphatec operating marginIntellia Therapeutics operating marginAlphatec revenue growthIntellia Therapeutics revenue growthAlphatec free cash flowIntellia Therapeutics free cash flow
Alphatec & Intellia Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.